YAP1 and neoplasm: In addition, verteporfin treatment resulted in the downregulation of tumor p-STAT3 and PD-L1 expression, along with YAP and CTGF, highlighting the ability of verteporfin to modulate PD-L1 expression in HR tumors (Fig. 5C, D).